…
Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Goodness Growth Holdings Inc is an OTCQX-listed holding company with limited public disclosure, so its core operations and portfolio are not clearly documented in widely available filings. Long-term prospects likely hinge on the performance of its underlying assets and successful portfolio execution, which could appeal to investors if transparency and scale improve.
Primary risks are limited transparency and low OTC liquidity, concentration and execution risk in underlying assets, and exposure to regulatory and financing uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -39.91M | -16.89M | -17.82M | -36.56M | -29.57M |
| Net income | -68.11M | -28.01M | -25.55M | -42.46M | -33.69M |
| Selling general administrative | 99.85M | 31.69M | 32.38M | 36.52M | 38.84M |
| Gross profit | 127.10M | 50.77M | 44.10M | 30.91M | 19.80M |
| Reconciled depreciation | 21.96M | 3.36M | 3.60M | 1.33M | 1.44M |
| Ebit | - | - | - | - | -18.99M |
| Ebitda | - | - | - | -12.64M | -17.55M |
| Non operating income net other | - | - | - | - | 1.49M |
| Operating income | 10.16M | 18.07M | 10.58M | -6.94M | -20.48M |
| Other operating expenses | - | - | - | - | 4.08M |
| Interest expense | 30.25M | 31.19M | 31.26M | 22.59M | 10.58M |
| Tax provision | 28.20M | 11.11M | 7.72M | 5.89M | 4.12M |
| Net interest income | -30.25M | -31.19M | -31.26M | -22.59M | -10.58M |
| Income tax expense | - | - | - | - | 5.46M |
| Total revenue | 268.77M | 99.38M | 88.13M | 74.63M | 54.45M |
| Total operating expenses | 258.61M | 81.32M | 77.55M | 81.57M | 40.28M |
| Cost of revenue | 141.67M | 48.61M | 44.03M | 43.72M | 32.01M |
| Total other income expense net | -19.82M | -3.77M | 2.86M | -7.03M | 1.49M |
| Net income from continuing ops | -68.11M | -28.01M | -25.55M | -42.46M | -35.03M |
| Net income applicable to common shares | - | - | - | - | -33.69M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 817.15M | 278.86M | 183.26M | 159.16M | 166.97M |
| Intangible assets | 117.47M | 7.90M | 8.72M | 8.78M | 10.18M |
| Other current assets | - | - | - | - | 1.56M |
| Total liab | 509.73M | 223.30M | 199.31M | 155.72M | 123.96M |
| Total stockholder equity | 307.42M | 55.56M | -16.04M | 3.44M | 43.01M |
| Other current liab | 0.17M | 89.39M | 88.33M | 1.32M | 1.60M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -299.55M | -231.44M | -203.43M | -177.88M | -135.42M |
| Good will | 87.53M | 0.00M | 0.00M | 0.18M | 0.18M |
| Other assets | - | - | - | - | 6.96M |
| Cash | 102.23M | 91.60M | 15.96M | 15.15M | 15.16M |
| Total current liabilities | 191.53M | 135.47M | 179.47M | 29.71M | 16.41M |
| Net debt | 51.61M | - | 53.40M | 42.88M | 12.17M |
| Short long term debt | 17.59M | 0.90M | 60.22M | 11.78M | - |
| Property plant equipment | - | - | - | - | 108.00M |
| Total current assets | 305.11M | 230.37M | 148.85M | 46.73M | 41.64M |
| Long term investments | 6.00M | 0.00M | - | - | 3.75M |
| Net tangible assets | - | - | - | - | 32.64M |
| Short term investments | 1.02M | 0.00M | - | - | - |
| Net receivables | 12.67M | 2.87M | 2.26M | 1.42M | 4.50M |
| Long term debt | 136.24M | 71.30M | 9.14M | 46.25M | 27.33M |
| Inventory | 59.97M | 21.67M | 19.29M | 20.51M | 20.42M |
| Accounts payable | 18.87M | 2.30M | 1.77M | 1.91M | 14.81M |
| Retained earnings total equity | - | - | - | - | -135.42M |
| Non currrent assets other | - | - | - | - | 109.72M |
| Non current assets total | 512.04M | 48.49M | 34.41M | 112.43M | 1.50M |
| Capital lease obligations | 149.86M | 17.89M | 11.43M | 81.44M | 81.83M |
| Long term debt total | - | - | - | - | 27.33M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -8.13M | -3.48M | -5.62M | 1.15M |
| Change to liabilities | - | - | - | - | 2.65M |
| Total cashflows from investing activities | - | - | - | - | -7.21M |
| Net borrowings | 18.26M | 13.09M | 5.26M | - | 26.15M |
| Total cash from financing activities | 18.42M | 94.01M | 5.26M | 23.68M | 25.78M |
| Change to operating activities | - | - | - | - | 0.13M |
| Net income | -68.11M | -28.01M | -25.55M | -42.46M | -33.69M |
| Change in cash | 30.89M | 75.64M | 0.82M | -0.01M | -11.95M |
| Begin period cash flow | 91.60M | 15.96M | 15.15M | 15.16M | 27.11M |
| End period cash flow | 122.49M | 91.60M | 15.96M | 15.15M | 15.16M |
| Total cash from operating activities | 3.71M | -10.23M | -0.97M | -18.07M | -30.52M |
| Issuance of capital stock | 0.00M | 80.83M | 0.00M | - | 0.00M |
| Depreciation | 21.96M | 3.36M | 3.60M | 1.33M | 3.37M |
| Other cashflows from investing activities | - | - | - | - | 14.82M |
| Change to inventory | -8.70M | -2.39M | -1.82M | -3.99M | -10.35M |
| Change to account receivables | -6.06M | -1.03M | 1.45M | 0.23M | -3.49M |
| Sale purchase of stock | - | - | - | - | 1.21M |
| Other cashflows from financing activities | - | - | - | - | -1.58M |
| Change to netincome | - | - | - | - | 4.80M |
| Capital expenditures | 29.82M | 11.69M | 6.05M | 5.56M | 23.18M |
| Change receivables | - | - | - | - | -3.49M |
| Cash flows other operating | - | - | - | - | 6.19M |
| Cash and cash equivalents changes | - | - | - | - | -11.95M |
| Change in working capital | 1.80M | 5.10M | 2.30M | -4.72M | -11.05M |
| Stock based compensation | 12.95M | 3.54M | 4.16M | 2.89M | 5.18M |
| Other non cash items | 9.21M | 5.75M | 9.88M | 16.83M | 10.67M |
| Free cash flow | -26.11M | -21.93M | -7.02M | -23.63M | -48.56M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MKKGY Merck KGaA ADR |
-0.68 2.09% |
31.83 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
163.45 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.38 1.77% |
21.79 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
43.05 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
207 South Ninth Street, Minneapolis, MN, United States, 55402
612 999 1606
385
| Name | Title | Year Born |
|---|---|---|
| Dr. Kyle E. Kingsley M.D. | Founder, Chairman & CEO | 1975 |
| Mr. Joshua Nathaniel Rosen | Interim Pres & Director | 1973 |
| Mr. John A. Heller | Chief Financial Officer | 1969 |
| Mr. Eric Greenbaum J.D. | Chief Scientific Officer | 1979 |
| Ms. Amber H. Shimpa | Chief Admin. Officer & Director | 1979 |
| Mr. Sam Gibbons | VP of Investor Relations | NA |
| Mr. J. Michael Schroeder | Chief Compliance Officer, Company Sec. & Gen. Counsel | 1967 |
| Mr. Albert Zakes | VP of Corp. Communications | NA |
| Mr. Harris Rabin | Chief Marketing Officer | 1975 |
| Dr. Stephen M. Dahmer M.D. | Chief Medical Officer | 1975 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.